axovant
participate
upcoming
october
conferences
provide
program
update
morning
october
new
york
globe
newswire
axovant
gene
therapies
nasdaq
axgt
company
developing
innovative
gene
therapies
today
announced
company
present
upcoming
conferences
announce
safety
efficacy
data
second
cohort
program
morning
tuesday
october
additionally
previously
announced
company
hold
parkinson
disease
r
day
friday
october
information
upcoming
presentations
found
chardan
annual
genetic
medicines
conference
date
tuesday
october
time
pm
et
participation
format
fireside
chat
gbola
amusa
md
cfa
head
hc
research
webcast
link
https
webcast
axgt
axovant
participate
investor
meetings
conference
arm
virtual
cell
gene
meeting
mesa
date
tuesday
october
time
pm
pt
pm
et
presentation
format
panel
discussion
cell
gene
therapies
chronic
conditions
presenter
pavan
cheruvu
md
chief
executive
officer
axovant
gene
therapies
parkinson
disease
r
day
date
friday
october
time
pm
et
moderator
gavin
corcoran
md
chief
r
officer
axovant
gene
therapies
registration
link
https
webinar
register
live
webcast
presentations
available
events
section
axovant
website
replays
available
approximately
days
following
conferences
axovant
gene
therapies
axovant
gene
therapies
gene
therapy
company
focused
developing
pipeline
innovative
product
candidates
debilitating
neurodegenerative
diseases
current
pipeline
gene
therapy
candidates
target
gangliosidosis
gangliosidosis
also
known
disease
sandhoff
disease
parkinson
disease
axovant
focused
accelerating
product
candidates
clinical
trials
team
experts
gene
therapy
development
external
partnerships
leading
gene
therapy
organizations
information
visit
contacts
media
investors
